HUP0400946A3 - A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug - Google Patents

A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug

Info

Publication number
HUP0400946A3
HUP0400946A3 HU0400946A HUP0400946A HUP0400946A3 HU P0400946 A3 HUP0400946 A3 HU P0400946A3 HU 0400946 A HU0400946 A HU 0400946A HU P0400946 A HUP0400946 A HU P0400946A HU P0400946 A3 HUP0400946 A3 HU P0400946A3
Authority
HU
Hungary
Prior art keywords
ethoxy
phenyl
propanoic acid
tert
pharmaceutical combination
Prior art date
Application number
HU0400946A
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HUP0400946A2 publication Critical patent/HUP0400946A2/hu
Publication of HUP0400946A3 publication Critical patent/HUP0400946A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
HU0400946A 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug HUP0400946A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101980A SE0101980D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001038 WO2002096402A1 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug

Publications (2)

Publication Number Publication Date
HUP0400946A2 HUP0400946A2 (hu) 2004-08-30
HUP0400946A3 true HUP0400946A3 (en) 2007-11-28

Family

ID=20284362

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0400946A HUP0400946A3 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug

Country Status (25)

Country Link
US (1) US20040152771A1 (hu)
EP (2) EP1666034A1 (hu)
JP (1) JP2004532864A (hu)
KR (1) KR20040008202A (hu)
CN (1) CN1535144A (hu)
AT (1) ATE336993T1 (hu)
BR (1) BR0210128A (hu)
CA (1) CA2448643A1 (hu)
CO (1) CO5540375A2 (hu)
CZ (1) CZ20033234A3 (hu)
DE (1) DE60214185T2 (hu)
EE (1) EE200300584A (hu)
ES (1) ES2269686T3 (hu)
HK (1) HK1062813A1 (hu)
HU (1) HUP0400946A3 (hu)
IL (1) IL159033A0 (hu)
IS (1) IS7058A (hu)
MX (1) MXPA03011005A (hu)
NO (1) NO20035237D0 (hu)
PL (1) PL367891A1 (hu)
RU (1) RU2003136154A (hu)
SE (1) SE0101980D0 (hu)
SK (1) SK14702003A3 (hu)
WO (1) WO2002096402A1 (hu)
ZA (1) ZA200309264B (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201636015A (zh) * 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
ATE266409T1 (de) * 2000-04-13 2004-05-15 Pfizer Prod Inc Synergistische wirkung von glyburide und milrinone

Also Published As

Publication number Publication date
DE60214185D1 (en) 2006-10-05
BR0210128A (pt) 2004-06-08
HK1062813A1 (en) 2004-11-26
WO2002096402A1 (en) 2002-12-05
EP1666034A1 (en) 2006-06-07
EE200300584A (et) 2004-02-16
CN1535144A (zh) 2004-10-06
EP1404309B1 (en) 2006-08-23
MXPA03011005A (es) 2004-02-27
SK14702003A3 (sk) 2004-09-08
ES2269686T3 (es) 2007-04-01
NO20035237D0 (no) 2003-11-25
SE0101980D0 (sv) 2001-06-01
EP1404309A1 (en) 2004-04-07
ZA200309264B (en) 2005-02-28
CZ20033234A3 (cs) 2004-12-15
ATE336993T1 (de) 2006-09-15
JP2004532864A (ja) 2004-10-28
US20040152771A1 (en) 2004-08-05
HUP0400946A2 (hu) 2004-08-30
PL367891A1 (en) 2005-03-07
KR20040008202A (ko) 2004-01-28
IS7058A (is) 2003-11-28
DE60214185T2 (de) 2007-07-19
CO5540375A2 (es) 2005-07-29
CA2448643A1 (en) 2002-12-05
IL159033A0 (en) 2004-05-12
RU2003136154A (ru) 2005-02-10

Similar Documents

Publication Publication Date Title
HK1090294A1 (en) Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4- oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and a biphosphonate ;
DK1660482T3 (da) 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-mehtyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester-methansulfonat og dennes anvendelse som lægemiddel
DK1870100T3 (da) 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsyre-ethylester-methansulfonat
NO20022591D0 (no) Finmalt form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}etoksy)fenyl]propansyre
EE200200278A (et) (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhappe kristalne vorm
DK1207868T3 (da) Farmaceutiske tramadolsalte
JP2006068522A (ja) おもちゃ組立ブロック
IL159034A0 (en) A pharmaceutical combination comprising either (s) -2-ethoxy-3-[4- (2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}- (s) -2- ethoxy propanoic acid and insulin
HUP0400946A3 (en) A pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl]propanoic acid or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl)ethoxy]phenyl}-(s)-2-ethoxy propanoic acid and a biguanide drug
USD563561S1 (en) Dental cassette
IL159035A0 (en) A pharmaceutical combination comprising either (s) -2-ethoxy-3- [4- (2-{4-methane sulfonyl oxyphenyl}ethoxy) phenyl] propanoic acid or 3- {4- [2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}- (s) -2-ethoxy propanoic acid and a sulfonylurea
IL172633A0 (en) Amine salts of (-)-2-{[2-(4-hydroxyphenyl) ethyl]thio}-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}
IL172376A0 (en) Process for the preparation of racemic 2{[2-(4- hydroxyphenyl)ethyl]thio}-3-[4-(2-{4- [(methylsulphonyl)oxy]phenoxy}ethyl)phenyl]-propanoic acid
AU2002365626A1 (en) Process for the preparation of (2s)-3-(4-({(4-(aminocarbonyl)-1-piperidinyl)carbonyl}oxy) phenyl)2-{((2s)-4-methyl-2-{(2-(2-methylphenoxy)acetyl)amino}pentanoyl)amino(propanoic acid and intermediates therefore
USD478358S1 (en) Information storage cartridge for electronic game machine
IS8234A (is) Kalíum- eða natríumsalt (-)-2-{[2-(4-hýdroxýfenýl)etýl]þíó}-3-[4-(2-{4-[(metýlsúlfónýl)oxý]fenoxý}fenýl]própansýru og notkun þeirra í læknisfræði
JP2003276736A (ja) カード取付構造
JP4263214B2 (ja) ディスク型の情報担体用の筐体
NL1025691A1 (nl) Kristallijn S-[c2-[c(1-iminoethyl)amino]ethyl]-2-methyl-L-cysteïne- maleaat-hydrochloride-zout.
DE60142063D1 (de) (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propion säureisopropylester, dessen herstellung und dessen verwendung
AU2001277736A1 (en) 2-(5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidyl)-n-(1-(2-( -t-butyl-1,3,4-oxadiazolyl)carbonyl)-2-(r,s)-methylpropyl) acetamide hydrochloride

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees